Bond Royalty Pharma 3.35% ( US78081BAP85 ) in USD
| Issuer | Royalty Pharma | ||||||||||||||||||
| Market price | |||||||||||||||||||
| Country | United States
|
||||||||||||||||||
| ISIN code |
US78081BAP85 ( in USD )
|
||||||||||||||||||
| Interest rate | 3.35% per year ( payment 2 times a year) | ||||||||||||||||||
| Maturity | 02/09/2051 | ||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||
| Total amount | 700 000 000 USD | ||||||||||||||||||
| Cusip | 78081BAP8 | ||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||
| Next Coupon | 02/03/2027 ( In 167 days ) | ||||||||||||||||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAP85, pays a coupon of 3.35% per year. The coupons are paid 2 times per year and the Bond maturity is 02/09/2051 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAP85, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAP85, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||
| |||||||||||||||||||
Français
Italiano
United States